Masaru Hori

Nagoya University

Papers

2

Total Citations

320

H-Index

2

About

Masaru Hori is a pioneering figure in plasma science and engineering, whose work has opened transformative applications in biomedicine. His primary research areas include nonequilibrium atmospheric pressure plasma (NEAPP), plasma–biology interactions, and the development of novel plasma sources for cancer therapy. Hori’s most impactful contribution is the demonstration that NEAPP can selectively induce apoptosis in ovarian cancer cells while sparing normal fibroblasts, a breakthrough published in 2012 that has garnered 314 citations. This work established a non‑thermal, targeted approach to cancer treatment, moving plasma medicine from concept to practical therapeutic potential. By showing that continuous plasma exposure can detach malignant cells from culture surfaces, Hori provided a mechanistic foundation for plasma‑based oncology. His achievements have positioned him as a leader in the emerging field of plasma‑activated cancer therapy, influencing subsequent studies on reactive species‑mediated cell death. For students and researchers, Hori’s research exemplifies how fundamental plasma physics can be harnessed for precise, minimally invasive medical interventions, bridging engineering and clinical science.

Research Focus

Key Achievements

2
H-Index
2
Papers
320
Total Citations
160
Avg Citations/Paper
🏆 Most Cited Paper
Selective killing of ovarian cancer cells through induction of apoptosis by nonequilibrium atmospheric pressure plasma
314 citations · 2012
📈 Most Prolific Year: 2012 (2 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Nagoya University

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago